» Articles » PMID: 39917257

Stratifying and Predicting Progression to Acute Liver Failure During the Early Phase of Acute Liver Injury

Overview
Journal PNAS Nexus
Date 2025 Feb 7
PMID 39917257
Authors
Affiliations
Soon will be listed here.
Abstract

Acute liver failure (ALF) is a serious disease that progresses from acute liver injury (ALI) and that often leads to multiorgan failure and ultimately death. Currently, effective treatment strategies for ALF, aside from transplantation, remain elusive, partly because ALI is highly heterogeneous. Furthermore, clinicians lack a quantitative indicator that they can use to predict which patients hospitalized with ALI will progress to ALF and the need for liver transplantation. In our study, we retrospectively analyzed data from 319 patients admitted to the hospital with ALI. By applying a machine-learning approach and by using the SHapley Additive exPlanations (SHAP) algorithm to analyze time-course blood test data, we identified prothrombin time activity percentage (PT%) as a biomarker reflecting individual ALI status. Unlike previous studies predicting the need for liver transplantation in patients with ALF, our study focused on PT% dynamics. Use of this variable allowed us to stratify the patients with highly heterogeneous ALI into six groups with distinct clinical courses and prognoses, i.e. self-limited, intensive care-responsive, or intensive care-refractory patterns. Notably, these groups were well predicted by clinical data collected at the time of admission. Additionally, utilizing mathematical modeling and machine learning, we assessed the predictability of individual PT% dynamics during the early phase of ALI. Our findings may allow for optimizing medical resource allocation and early introduction of tailored individualized treatment, which may result in improving ALF prognosis.

References
1.
Price G, Heinz M, Song S, Nemesure M, Jacobson N . Using digital phenotyping to capture depression symptom variability: detecting naturalistic variability in depression symptoms across one year using passively collected wearable movement and sleep data. Transl Psychiatry. 2023; 13(1):381. PMC: 10710399. DOI: 10.1038/s41398-023-02669-y. View

2.
Mochida S, Takikawa Y, Nakayama N, Oketani M, Naiki T, Yamagishi Y . Diagnostic criteria of acute liver failure: A report by the Intractable Hepato-Biliary Diseases Study Group of Japan. Hepatol Res. 2011; 41(9):805-12. DOI: 10.1111/j.1872-034X.2011.00860.x. View

3.
Kawakami E, Kobayashi N, Ichihara Y, Ishikawa T, Choe H, Tomoyama A . Monitoring of blood biochemical markers for periprosthetic joint infection using ensemble machine learning and UMAP embedding. Arch Orthop Trauma Surg. 2023; 143(10):6057-6067. DOI: 10.1007/s00402-023-04898-8. View

4.
dos Santos D, Neves P, Azeredo E, Pelajo-Machado M, Martinho J, Pacheco-Moreira L . Activated lymphocytes and high liver expression of IFN-γ are associated with fulminant hepatic failure in patients. Liver Int. 2011; 32(1):147-57. DOI: 10.1111/j.1478-3231.2011.02654.x. View

5.
Glavinic R, Marcic L, Dumancic S, Pavicic Ivelja M, Jelicic I, Kalibovic Govorko D . Acute Arterial Thrombosis of Lower Extremities in COVID-19 Patients. J Clin Med. 2022; 11(6). PMC: 8949095. DOI: 10.3390/jcm11061538. View